RxDoctor Payments Data

Miranda Sudduth

Medical · Madison, MSNPI 1962804211

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 467 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 39.1% of the total. Among medical clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,886in general payments, 2019–2025

Across 467 payments — averaging $16.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Amgen$2K
  • Novartis$592
  • Johnson & Johnson$504
  • Lilly USA, LLC$315
  • Mallinckrodt Hospital Products Inc.$311
  • plus $1K from 12 others

What the payments were for

  • Food & beverage$7,886100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,886 in reported general payments places this provider in the 90th percentile of 65 medical providers in Mississippi.

See all medical providers in Mississippi

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf)Adalimumab13$92,486
Cimzia (2 Pack)Certolizumab Pegol11$65,858
OrenciaAbatacept/Maltose11$31,800
Hydroxychloroquine Sulfate210$8,548
Celecoxib40$3,087
Leflunomide32$1,817
Duloxetine Hcl65$1,299
MethotrexateMethotrexate Sodium47$1,170
Gabapentin64$967
Azathioprine14$590
Cyclobenzaprine Hcl35$573
Sulfasalazine19$558
Pregabalin19$264
Diclofenac Sodium11$253
Levothyroxine Sodium11$225

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieHumira(Cf)$3,085$92,48613 claims
UCB, Inc.Cimzia (2 Pack)$182$65,85811 claims
E.r. Squibb & Sons, L.L.C.Orencia$18$31,80011 claims
Fresenius Kabi USA, LLCSodium Chloride$41$1416 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 65 medical providers in Mississippi.

Other medical in Madison

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →